Meet the PI Lecture May 30, 2014, 12:00 pm - 1:30 pm WPIC Auditorium
Neurocognitive Correlates and Consequences of Diabetes:
A Lifespan Analysis
Christopher M. Ryan, PhD
Professor of Psychiatry, Psychology,
Health and Community Systems (Nursing),
and Clinical and Translational Science
University of Pittsburgh
Dr. Christopher Ryan is Professor of Psychiatry and Professor of Psychology, Health & Community Systems, and Clinical and Translational Science at the University of Pittsburgh. A clinical neuropsychologist by training, he received his PhD at the University of California, Berkeley in 1976, and completed post-doctoral training in Boston, under the direction of Dr. Nelson Butters. In 1980 he joined the Department of Psychiatry at the University of Pittsburgh School of Medicine and initiated a series of research studies on cognitive function in adolescents with type 1 diabetes. His subsequent work has focused on individuals with a variety of chronic conditions including diabetes, hypertension, alcoholism, hypercholesterolemia, and breast cancer, as well as exposure to neurotoxins in the workplace (solvents; heavy metals) and in utero (tobacco; alcohol and other drugs). He has also been responsible for overseeing the longitudinal cognitive assessments of participants followed for more than 25 years in the Diabetes Control and Complications, as well as for developing cognitive assessments for several Pharma-sponsored clinical trials. His experimental research has examined the effects of acute hypo- and hyperglycemia on changes in cognition in children and adults. He has actively collaborated with multiple groups of researchers around the world, and has published more than 150 peer reviewed articles and book chapters. In addition to his active research program, he has taken on research administration responsibilities and now serves as the Director of the University Institutional Review Board and as the Co-Director of the Regulatory Knowledge and Support Core of the University’s Clinical and Translational Science Institute.
Learning Objectives: At the conclusion of this lecture, participants will be able to:
- Identify the neurocognitive phenotypes associated with type 1, and type 2, diabetes in both children and adults.
- Describe the key biomedical risk factors that increase the likelihood that any individual will manifest neurocognitive dysfunction.
- Characterize the changes in brain structure that may underlie the development of cognitive dysfunction.
Continuing Education Credit: The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits TM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded .15 continuing education units (CEUs), which are equal to 1.5 contact hours. In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, information about relationships of presenters with commercial interests (if any) will be included in materials which will be distributed at the time of the conference. WPIC is approved by the American Psychological Association to offer continuing education for psychologists. WPIC maintains responsibility for this program and its contents. This program is being offered for 1.5 continuing education credits.
For more information on this lecture and other events, please contact Courtney Wallace at firstname.lastname@example.org.